David P. Hochman - 08 May 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Chief Executive Officer and Chairperson, Director
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
08 May 2024
Net transactions value
$0
Form type
4
Filing time
10 May 2024, 17:22:52 UTC
Previous filing
24 Jul 2023
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +100,000 +21% $0.000000 565,498 08 May 2024 Direct F1
transaction OBIO Common Stock Award $0 +100,000 +44% $0.000000 327,502 08 May 2024 By the DPH 2008 Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on June 10, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on September 10, 2025, November 10, 2025, December 10, 2025, June 10, 2026, September 10, 2026, December 10, 2026, March 22, 2027, June 10, 2027, September 10, 2027, December 10, 2027, March 22, 2028 and June 10, 2028, subject to the Reporting Person's continuous service through such dates.

Remarks:

Chief Executive Officer and Chairperson